Institutional investors purchased a net $1.0 million shares of ADXS during the quarter ended October 2013. This may signal that the smart money is gaining interest in this company as the 7.64% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CATALYST CAPITAL ADVISORS LLC Bought 300.0 Thousand shares of Advaxis Inc
KNOLL CAPITAL MANAGEMENT LP Bought 225.0 Thousand shares of Advaxis Inc